Seattle, WA (PRWEB) March 28, 2014
Quorum Review IRB, the industry leader in central IRB services, announces Mitchell E. Parrish, JD, RAC, CIP, as a session moderator and presenter at the event Clinical Study Teamwork: Building Effective Partnerships. The event takes place April 10, 2014 in Raleigh-Durham/RTP, North Carolina.
Mr. Parrish will moderate an expert panel of speakers on the topic of Proxy Consent for Children and the Cognitively Impaired at 11:55 AM on April 10, 2014. The panel will present best practices in consenting vulnerable subjects, strategies for working with special populations, and PI/IRB roles and responsibilities when consenting children and special populations.
Mr. Parrish is a Regulatory Attorney for Quorum Review, where he provides legal counsel on regulatory issues and FDA requirements associated with research and development of medical products. Mr. Parrish is a member of the Regulatory Affairs Professionals Society, Public Responsibility in Medicine & Research, American Association of Corporate Counsel, and Washington State Bar Association. He is also a Certified IRB Professional (CIP) and guest lectures for the Masters of Science Program in Biomedical Regulatory Affairs at the University of Washington. Prior to Quorum, Mr. Parrish served as Regulatory Counsel for Western IRB and as a Regulatory Consultant for the National Cancer Institute.
Clinical Study Teamwork: Building Effective Partnerships is a two-day conference presented by the International Institute for Business Information and Growth (iiBIG). The conference brings together Global clinical research leaders in pharma, biotech, medical device, and related industries to share their experiences and insights in order to enhance the clinical research and operations learning experience for attendees.
For the latest on Quorum Review News and Events, visit http://www.quorumreview.com.
About Quorum Review IRB
Quorum Review is an independent institutional review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing ethics review of human clinical research since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.
Quorum’s best-in-class IRB services include 15 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, international ethics review, a specialized Phase I team, and unique processes for post-approval and registry studies.